Appointed Director of BioPharmaChem Ireland in 2023, after a decade leading Ibec’s Medtech and Engineering sector group. Twenty years in life sciences at Ibec, sitting on the industry advisory board for SSPC and the national association boards of Cefic (EFCG) and EuropaBio. Holds a PhD in the physics of molecular materials and nanotechnology.

Leads NIBRT’s transformation agenda across digital, data and AI, including its new Digital Academy and the digitisation of its GMP-like training and research facility. Previously 20+ years in senior technology roles at Glanbia plc, culminating as Global Head of IT.

Leads the global engineering function at Teleflex, covering process development, maintenance, facilities, capital investment and footprint management. Built 14 years in pharma across operations, maintenance and new product introduction before moving into medical devices, holding senior global operations and engineering technology roles at Hollister.

Joined Eirgen Pharma in 2021 as Head of Engineering, expanding its high-potency development and manufacturing. Appointed COO in 2026, overseeing manufacturing, supply chain, engineering and operational excellence, with 20+ years across Terumo, Cook Medical and Boston Scientific.

Regulatory compliance, commissioning, qualification and validation expert with 25+ years across pharma and biotech. Deep knowledge of aseptic processing, biotech products and medical devices, applying FDA and ICH guidance to build risk-based approaches.

Independent Life Sciences & Pharma consultant who founded and led BioPharmaChem Ireland at Ibec for three decades. Now a strategic advisor to Innoglobal and Innopharma.

Joined ABM in 2025 as Vice President of Operations for Ireland, bringing more than 30 years’ experience in facilities management. Drives growth, operational excellence and service innovation across ABM’s manufacturing, pharma, data centre and healthcare clients.

Biopharma R&D executive with three decades driving innovation from ideation to post-market approval. Former President of Ferring Research Institute and Global Head of Drug Discovery at Janssen, with four product approvals and 80+ projects progressed to development.

Leads Biostor Ireland, an EU-licensed cell bank and biobank for certified storage and worldwide distribution of biological materials. Brings a compliance-first view to AI adoption; his talk, Building Trust in AI, covers the governance, validation and transparency frameworks regulated life science organisations need.

Leads the research team in computational design of advanced materials at UL’s Bernal Institute, partnering with world-leading experimental and industry groups on nano-enabled products for health and sustainability. Author of 180+ articles in journals including Nature, Nature Materials and Nature Nanotechnology.

Advancing digital manufacturing across a global GMP-regulated network. Works across manufacturing systems, automation, MES, data and analytics, applying technology and AI to create value for manufacturing teams.

More than 25 years partnering with life science customers worldwide to design and deliver manufacturing and digital technologies. Leads Cognizant’s life science manufacturing consulting practice and sits on its AI Adoption Council.